Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

1,500

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2026

Conditions

Hepatitis BCarcinoma, Hepatocellular

Interventions

DRUG

Vitamin D3

Participants with chronic hepatitis B will take 800 IU of vitamin D3 per day by mouth besides the anti-virus treatment with nucleos(t)ide medicine

All Listed Sponsors

lead

Third Affiliated Hospital, Sun Yat-Sen University

OTHER